Medindia

X

Life BioScience, Inc. Receives $150K Grant to Develop Advanced Electronics Packaging for Commercial and Military Applications

Friday, April 9, 2010 Press Release J E 4
Advertisement


ALBUQUERQUE, N.M., April 8 Life BioScience, Inc. (LBSI) has received a grant totaling $150,000 from the National Science Foundation (NSF) for further development of its proprietary glass ceramic platform for next generation electronic packaging substrates. These novel substrates will integrate a number of enhancements into a single substrate that includes high density copper interconnects, high pressure microfluidics for thermal management requirements and optical waveguide systems.

Over the last decade, packaging was considered a secondary issue after integrated circuit development, but increasing costs and substrate material limitations have brought it to the forefront. This NSF project directly addresses these cost and material constraints. The current market for traditional electronics packaging exceeds $6B a year, but is facing extreme performance and environmental challenges.

"There is a significant need for advancements in electronics packaging to meet the requirements for electronics systems of the future, in both commercial and military applications," said Blake Ridgeway, LBSI President and CEO. "The superior performance of our glass ceramic substrate is expected to meet these future requirements in a shorter timeline than what is currently projected by the electronics industry."

LBSI's research is being conducted in its offices in Albuquerque, NM. This funding is part of the federal government's Small Business Innovative Research (SBIR) program.

Life BioScience, Inc. (LBSI), is an emerging growth company that has pioneered a revolutionary series of glass ceramic-based materials that will provide a new product platform for markets as diverse as aerospace, telecommunications, electronics packaging and life sciences. Formed in 2006, the company's work to date has resulted in the release of the APEX(TM) Glass series and the ORACLE(TM) Glass series.

SOURCE Life BioScience, Inc.
Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
RAZCODE Connected Health Gateway Integrates with D...
S
Keryx Biopharmaceuticals, Inc. Initiates Phase 3 R...